fda draft guidance: rare disease clinical trials
Published 4 years ago • 262 plays • Length 11:19Download video MP4
Download video MP3
Similar videos
-
5:26
central rating | basics and benefits for rare disease clinical trials
-
57:01
decentralized clinical trials (dct) draft guidance
-
1:54
fda providing new grants for natural history studies in rare diseases
-
1:01:48
in the spotlight: recent fda updates and guidance for rare disease drug development
-
55:45
cpag webinar: working with the fda in the conduct of clinical trials
-
1:00
recruiting for rare disease #decentralizedtrials #fda #raredisease #shorts
-
40:30
rare disease clinical trials - being informed
-
1:26:23
diversity in clinical trials: learn about enrollment trends and resources from fda
-
45:04
the fda's drug approval process
-
19:38
take care of rare #6 fabry disease and the brain #part1
-
31:16
fda guidance on conduct of clinical trials of medical products during the public health emergency
-
2:55
dina zand's work on rare diseases
-
53:59
increasing diversity in clinical trials fda guidance and industry efforts
-
1:16:44
cpag webinar: an introduction to clinical trials
-
3:44
rare disease challenges in each step of the drug development process
-
13:21
overview of the fda product-specific guidance program
-
7:34:28
fda's rare disease day 2024—dedicated to patients and providers
-
25:53
janet woodcock, md | fda cder re-organization and impact on rare diseases
-
57:06
optimizing rare disease trials: trial design & execution
-
0:50
accelerating rare disease drug development
-
2:58
fda/rare diseases
-
40:26
rare disease clinical trials webinar: involving the patient community